Skip to content
HowShorted

Accendra Health, Inc. short interest in 2022

In 2022, Accendra Health, Inc.'s disclosed short interest ran from 8.66% of shares outstanding on 14 Jan 2022 to 7.50% on 30 Dec 2022, a change of -1.16 percentage points. The year's high was 11.25% on 31 Mar 2022 and its low 5.07% on 30 Nov 2022, averaging 8.68% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.55 days on 15 Jul 2022. Full history: Accendra Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Accendra Health, Inc. in 2022

2022 in figures

Start of year
8.66% (14 Jan 2022)
End of year
7.50% (30 Dec 2022)
Change
-1.16 pp
High
11.25% (31 Mar 2022)
Low
5.07% (30 Nov 2022)
Average
8.68%
Highest days to cover
13.55 (15 Jul 2022)
SEC filings marked
9

Every report in 2022

Accendra Health, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20228.66%6.69
31 Jan 20229.85%8.92
15 Feb 202210.73%11.31
28 Feb 202211.17%6.9310-K filed, results (8-K)
15 Mar 202211.21%11.95
31 Mar 202211.25%11.66
14 Apr 202210.99%11.02
29 Apr 202210.62%9.64
13 May 202210.02%7.18results (8-K), 10-Q filed
31 May 202210.12%11.18
15 Jun 20229.89%13.39
30 Jun 20229.14%8.42
15 Jul 20228.72%13.55
29 Jul 20228.33%10.15
15 Aug 20229.08%8.7610-Q filed, results (8-K)
31 Aug 20228.10%12.07
15 Sep 20227.41%7.66
30 Sep 20226.45%6.32
14 Oct 20226.96%3.71results (8-K)
31 Oct 20226.49%4.74
15 Nov 20225.39%3.5310-Q filed, results (8-K)
30 Nov 20225.07%7.49
15 Dec 20225.21%5.67
30 Dec 20227.50%6.68

See also: Accendra Health, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.